Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04903860
Other study ID # RBHP 2021 ERIVAN
Secondary ID 2021-A00363-38
Status Completed
Phase N/A
First received
Last updated
Start date July 12, 2021
Est. completion date July 27, 2022

Study information

Verified date July 2022
Source University Hospital, Clermont-Ferrand
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The main objective of the study is to compare the use of single-use ancillary reaming material during total hip replacement and conventional reusable ancillary reaming material. The assessment will focus on the medico-economic differences found in this prospective randomized study


Description:

In orthopaedics, the ancillary equipment is a generic term that includes all the instruments necessary for hip replacement surgery. The surgeon remains very dependent on these boxes of instruments, including rasps, reamers and trial implants (stems and trial heads), which are required in THR. Each instrument set is generally packaged in 2 or 3 boxes and each surgeon has a limited number of instrument sets at his disposal per operating day. Each ancillary device has a purchase cost, a maintenance cost (paid by the laboratories or distributors) and a sterilization cost, (paid by the health care institutions). Single-use reamers are instruments that are used on a single patient and then discarded. Performance and safety of use are optimized by providing a sterile and new product for each use. Therefore, it seems judicious to compare the medico-economic differences between the use of single-use reamers versus reusable reamers within a classic ancillary. This study will compare the costs incurred, the waste produced, the operating time, the satisfaction of the surgeon after the use of single-use reamers during total hip replacement, versus conventional re-sterilizable ancillary and verify the equivalence, three months after surgery, of clinical and radiological results.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date July 27, 2022
Est. primary completion date July 27, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - - Patient, male or female, over 18 years of age, eligible for a first-line total hip replacement for isolated coxarthrosis - Patient registered to the national health system - Patient able to understand information about the protocol and answer to questionnaire Exclusion Criteria: - Pregnant, breastfeeding or potentially pregnant woman - Major disability - History of hip replacement surgery - Any surgical and/or anesthetic contraindication, or any condition deemed by the investigator to be incompatible with the research. - Morbid obesity as defined by body mass index (BMI) >40 kg.m-2 - History of recent infection at the surgical site - Surgical contraindication - Refusal to participate

Study Design


Related Conditions & MeSH terms


Intervention

Device:
total hip replacement with single use ancillary
Comparison of the use of conventional ancillary reaming and single-use ancillary reaming material in total hip replacement
total hip replacement with conventional ancillary
Comparison of the use of conventional ancillary reaming and single-use ancillary reaming material in total hip replacement

Locations

Country Name City State
France CHU clermont-ferrand Clermont-Ferrand

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Clermont-Ferrand Groupe Lépine

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Overall cost of surgery Direct medical costing in both groups:
Sterilization costs,
Inventory management costs,
Material costs,
Waste management costs,
Operating room costs based on room occupancy times.
At 3 months
Secondary Surgical time Calculated from the beginning of the skin incision to closure and recorded on the anesthesia sheet intraoperative
Secondary Modified Merle d'Aubigné and Postel Method score The patients were evaluated by the Modified Merle d'Aubigné and Postel Method, which evaluates pain, gait and mobility, on a scale of 1 to 6 for each item, where 1 indicates the worst and 6, the best state of the patient. The total minimum score reached is 3, and the maximum is 18. Pré-opérative examination / At 3 months
Secondary Harris Hip Score This instrument has 10 items in 3 sections describing pain, function, range of motion, and deformity. The first section is questionnaire-based, answered by the patient, and includes impairments and activities. The second and third sections are administered by the therapist or physician, and include leg length measurement and range of motion (ROM) measures of the hip (flexion, abduction, external rotation and adduction). Each item has a unique numerical scale that corresponds to descriptive response options. The highest possible score is 100, with a higher score indicating less dysfunction. Pré-opérative examination / At 3 months
Secondary Charnley classification and Devane score Devane score: The purpose of this score is to specify the patient's activity level preoperatively. Initially established by Devane, it allows a classification of each patient in 5 categories from sedentary to athletic Charnley score: This is a commonly used score designed to assess the patient's overall disability in relation to gait function. It was published by Charnley and distinguishes patients into 3 categories Pré-opérative examination / At 3 months
Secondary WOMAC score The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) is a widely used, proprietary set of standardized questionnaires used by health professionals to evaluate the condition of patients with osteoarthritis of hip, including five items for pain (score range 0-20), two for stiffness (score range 0-8), and 17 for functional limitation (score range 0-68). Pré-opérative examination / At 3 months
Secondary HOOS score The hip disability and osteoarthritis outcome score (HOOS) is a questionnaire intended to be used to assess the patient's opinion about their hip and associated problems and to evaluate symptoms and functional limitations related to the hip during a therapeutic process. To interpret the score, the outcome measure is transformed in a worst to best scale from 0 to 100, with 100 indicating no symptoms and 0 indicating extreme symptoms. Pré-opérative examination / At 3 months
Secondary Pain evaluation The visual similar scale is auto completed. For the intensity of pain, the scale varies between "no pain" (the score of 0) and "most painful" (the score of 10). Pré-opérative examination / At 3 months
Secondary Operator satisfaction Operator satisfaction score (numerical scale from 0 (not satisfied) to 10 (very satisfied)) of the material during the surgical procedure through surgical intervention an average of 1 day
Secondary Radiological analysis realization of standard radiographs of the pelvis from the front, hip from the front and from the side. Analysis of the acetabulum according to Charnley and search for the presence of granulometry, migration or acetabular osteolysis. Measurement of the femoral and acetabular offset and height of the center of rotation At 3 months
Secondary Complications Analysis of possible intraoperative and postoperative complications and their costs: loosening, infection, dislocation, wear and implant fracture At 3 months
See also
  Status Clinical Trial Phase
Completed NCT04774562 - The Effect of Video-Assisted Discharge Education After Total Hip Replacement Surgery N/A
Recruiting NCT02793934 - The Pilot Project Development Of MEdical Rehabilitation System in Russian Federation
Completed NCT02554149 - Radiological Measurement of Femoral Stem Version Using Lateral Decubitus Method: A Prospective Study N/A
Completed NCT01228162 - Influence of Muscle Relaxation With Rocuronium Bromide During General Anaesthesia on Muscle Trauma and Postoperative Analgetic Consumption in Patients With Total Hip Prosthesis Implantation Phase 4
Completed NCT00219921 - Postoperative Analgesia After Total Hip Replacement Phase 3
Completed NCT02644096 - Rehabilitation of Patients After THR - Based on Patients´Selfrated Health Phase 1
Completed NCT02720471 - Local Analgesia Versus Local Peroperative Infiltration After Total Hip Replacement Phase 3
Completed NCT03218267 - The Postural Control in Patients After Total Hip Replacement N/A
Recruiting NCT03120312 - Short Term and Long Term Outcome for Elderly Patients Treated With Total Hip Replacement
Withdrawn NCT01523418 - Study to Observe Safety of Xarelto in VTE Prophlylaxis After Elective TKR (Total Knee Replacement) or THR (Total Hip Replacement) N/A
Recruiting NCT01782859 - Effect of Steroids on Thrombosis (Blood Clot Formation) and Inflammation in Patients Undergoing Hip Surgery N/A
Completed NCT00889148 - Morphine COnsumption in Joint Replacement Patients, With and Without GaBapentin Treatment, a RandomIzed ControlLEd Study N/A
Completed NCT05375565 - Comparative Effects of Weight Bearing and Non-weight Bearing Exercises in Patients With Total Hip Replacement N/A
Completed NCT04166539 - Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty
Completed NCT03072706 - Evaluation of X-ray, Acetabular Guides and CT in THR N/A
Not yet recruiting NCT02272205 - Evaluation of Conventional Antibiotic Prophylaxis During a Change of Hip or Knee Infected at a Time N/A
Completed NCT01522014 - Randomized Clinical Trial of Ceramic Bearing Primary Total Hip Arthroplasty Phase 4
Completed NCT06169878 - Efficiency of the Adjustable Lower Extremity Abduction Apparatus After Total Hip Replacement Surgery N/A
Recruiting NCT03240484 - Examining Effects of Spinal Fusion on Outcomes Following Total Hip Replacement
Completed NCT03424382 - CREATION Health Readmission Risk Assessment Tool